Skip to main content
Premium Trial:

Request an Annual Quote

Roche Gets FDA OK for MDx MRSA Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche said after the close of the market Thursday that the US Food and Drug Administration has cleared its LightCycler MRSA Advanced Test for detection of methicillin-resistant Staphylococcus aureus.

The PCR-based test is a qualitative in vitro diagnostic test for direct detection of nasal colonization with bacterial MRSA. It is designed to aid in preventing and controlling MRSA infections in healthcare settings and can provide results within two hours, said Roche.

The test is run on Roche's LightCycler real-time PCR instrument.

Last month, the FDA cleared for marketing Cepheid's latest test for MRSA, the Xpert SA Nasal Complete. That test is designed for the detection and differentiation of Staphylococcus aureas and methicillin-resistant Staphylococccus aureus colonization in under one hour, according to Cepheid.

Becton Dickinson also makes a molecular MRSA test that identifies and differentiates Staphylococcus aureas and methicillin-resistant Staphylococccus aureus.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.